A. Guerrieri-Gonzaga

发表

Long-term effects of inhaled budesonide on screening-detected lung nodules.

B. Bonanni, D. Radice, G. Veronesi, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women.

M. Cazzaniga, B. Bonanni, G. Pelosi, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women

M. Cazzaniga, B. Bonanni, S. Gandini, 2001, Breast Cancer Research and Treatment.

Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trial.

B. Bonanni, L. Baglietto, C. Robertson, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Hormonal Therapy and Chemoprevention

M. Cazzaniga, B. Bonanni, F. Pigatto, 2000, The breast journal.

Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy women.

B. Bonanni, S. Gandini, A. Barreca, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fenretinide (4-HPR): A Preventive Chance for Women at Genetic and Familial Risk?

M. Cazzaniga, A. Guerrieri-Gonzaga, C. Varricchio, 2012, Journal of biomedicine & biotechnology.

Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer

B. Bonanni, L. Baglietto, G. Veronesi, 2001, British Journal of Cancer.

Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.

M. Cazzaniga, B. Bonanni, G. Pelosi, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer.

B. Bonanni, P. Magni, S. Gandini, 2008, Cancer research.

Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study.

A. Luini, M. Cazzaniga, B. Bonanni, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen

B. Bonanni, G. Mellgren, S. Gandini, 2016, Breast Cancer Research and Treatment.

The Italian Breast Cancer Prevention Trial with Tamoxifen

N. Rotmensz, A. Decensi, A. Guerrieri-Gonzaga, 2001, Annals of the New York Academy of Sciences.

Response to Braillon

B. Bonanni, P. Brown, E. Szabo, 2021, JNCI cancer spectrum.

A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer

A. Luini, M. Cazzaniga, B. Bonanni, 2013, Breast Cancer Research.

Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users.

M. Cazzaniga, B. Bonanni, G. Pelosi, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect o f B lood T amoxifen C oncentrations o n S urrogate Biomarkers i n a T rial o f D ose R eduction i n H ealthy W omen

B. Bonanni, Alberto Costa, S. Gandini, 1999 .

Worry and risk perception of breast cancer in a prevention trial of low dose tamoxifen in midlife postmenopausal hormone users.

B. Bonanni, A. Decensi, M. Puntoni, 2017, Breast.

Association of Molecular Subtypes with Ki-67 Changes in Untreated Breast Cancer Patients Undergoing Pre-surgical Trials Epidemiology and Biostatistics

M. Cazzaniga, B. Bonanni, G. Pruneri, 2022 .

Association of Vitamin D Receptor and Vitamin D-Binding Protein Polymorphisms with Familial Breast Cancer Prognosis in a Mono-Institutional Cohort

B. Bonanni, S. Gandini, C. Zanzottera, 2021, Nutrients.

A Randomized, Placebo-Controlled, Phase II, Presurgical Biomarker Trial of Celecoxib Versus Exemestane in Postmenopausal Breast Cancer Patients

B. Bonanni, G. Pruneri, S. Gandini, 2016, Cancer Prevention Research.

Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive Disease

B. Bonanni, L. Boni, M. Digennaro, 2021, Clinical Cancer Research.

Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trial

B. Bonanni, G. Mellgren, L. Boni, 2021, NPJ breast cancer.

Quality of Life in a Randomized Breast Cancer Prevention Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal Women

B. Bonanni, S. Gandini, D. Serrano, 2018, Cancer Prevention Research.

Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia

B. Bonanni, L. Boni, M. Digennaro, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abstracts of the 4th meeting of the European Hereditary Tumour Group, Barcelona, Spain, October 17–19th, 2019

B. Bonanni, L. Kowalski, L. Bernard, 2020, Familial Cancer.

Effects of raloxifene on sex steroid hormones and C-telopeptide in postmenopausal women with primary breast cancer

A. Luini, M. Cazzaniga, B. Bonanni, 2006, Breast Cancer Research and Treatment.

A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast Cancer

M. Cazzaniga, B. Bonanni, G. Pruneri, 2017, Cancer Prevention Research.

Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial

B. Bonanni, G. Mellgren, P. Maisonneuve, 2011, The Pharmacogenomics Journal.

Abstract PD3-08: Effects of low dose tamoxifen on circulating risk biomarkers in a phase III trial in breast pre-invasive disease

B. Bonanni, L. Boni, M. Digennaro, 2020 .

Difficult choices for young patients with cancer: the supportive role of decisional counseling

B. Bonanni, S. Gandini, F. Peccatori, 2015, Supportive Care in Cancer.

Abstract P4-11-16: Low serum adiponectin level is an independent risk factor of DCIS in postmenopausal women at increased risk of breast cancer

J. Cuzick, B. Bonanni, S. Gandini, 2015 .

Response to Dominguez-Valentin M et al. 2019: Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database

B. Bonanni, S. Gandini, L. Bertario, 2019, Genetics in Medicine.

Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide

G. Mellgren, S. Gandini, A. Decensi, 2012, Breast Cancer Research and Treatment.

Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy women.

B. Bonanni, A. Barreca, C. Robertson, 1999, European journal of cancer.

Is tumor testing efficiency for Lynch syndrome different in rectal and colon cancer?

B. Bonanni, S. Gandini, L. Bertario, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Prognostic impact of germline BRCA1/2 pathogenic variants in breast cancer

B. Bonanni, S. Gandini, G. Corso, 2022, Breast Cancer Research and Treatment.

Tamoxifen and Metabolite Concentrations in Serum and Breast Cancer Tissue during Three Dose Regimens in a Randomized Preoperative Trial

G. Pelosi, D. Serrano, F. Pigatto, 2004, Clinical Cancer Research.

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

Katherine M. Tucker, Sebastian A. Wagner, Kelly J. Sullivan, 2019, Human Mutation.

Breast Cancer Prevention Trials Using Retinoids

M. Cazzaniga, B. Bonanni, D. Serrano, 2004, Journal of Mammary Gland Biology and Neoplasia.

Chemoprevention of breast cancer: The Italian experience

B. Bonanni, Alberto Costa, U. Veronesi, 2000, Journal of cellular biochemistry. Supplement.

Biologic activity of tamoxifen at low doses in healthy women.

B. Bonanni, P. Boyle, U. Veronesi, 1998, Journal of the National Cancer Institute.

Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast

B. Bonanni, G. Pruneri, G. Viale, 2020, Modern Pathology.

Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.

A. Luini, M. Cazzaniga, B. Bonanni, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is it Time to Test Metformin in Breast Cancer Clinical Trials?

M. Cazzaniga, B. Bonanni, A. Decensi, 2009, Cancer Epidemiology Biomarkers & Prevention.

Effect of Low-Dose Tamoxifen on Steroid Receptor Coactivator 3/Amplified in Breast Cancer 1 in Normal and Malignant Human Breast Tissue

B. Bonanni, G. Mellgren, S. Gandini, 2010, Clinical Cancer Research.

Microsatellite instability evaluation: which test to use for endometrial cancer?

B. Bonanni, A. Rappa, I. Betella, 2021, Journal of Clinical Pathology.

A Presurgical Study of Oral Silybin-Phosphatidylcholine in Patients with Early Breast Cancer

M. Cazzaniga, B. Bonanni, G. Pruneri, 2015, Cancer Prevention Research.

Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer.

M. Cazzaniga, B. Bonanni, G. Pruneri, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

A Two-by-Two Factorial Trial Comparing Oral with Transdermal Estrogen Therapy and Fenretinide with Placebo on Breast Cancer Biomarkers

M. Cazzaniga, B. Bonanni, L. Baglietto, 2004, Clinical Cancer Research.

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast

B. Bonanni, S. Loi, C. Denkert, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial

U. Hofmann, A. Luini, M. Cazzaniga, 2014, Breast Cancer Research and Treatment.

Vitamin D and overall mortality

S. Gandini, A. Guerrieri-Gonzaga, 2013, Pigment cell & melanoma research.

The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial

B. Bonanni, S. Gandini, D. Serrano, 2008, Ecancermedicalscience.

Lapatinib Activity in Premalignant Lesions and HER-2–Positive Cancer of the Breast in a Randomized, Placebo-Controlled Presurgical Trial

A. Luini, B. Bonanni, G. Pruneri, 2011, Cancer Prevention Research.

Ductal intraepithelial neoplasia: postsurgical outcome for 1,267 women cared for in one single institution over 10 years.

A. Luini, M. Cazzaniga, B. Bonanni, 2009, The oncologist.

Chemoprevention studies within lung cancer screening programmes

B. Bonanni, G. Veronesi, A. Guerrieri-Gonzaga, 2015, Ecancermedicalscience.

Randomized Phase II Trial of Inhaled Budesonide versus Placebo in High-Risk Individuals with CT Screen–Detected Lung Nodules

S. Ferretti, B. Bonanni, D. Radice, 2010, Cancer Prevention Research.

Effect of tamoxifen at low doses on ultrasensitive C‐reactive protein in healthy women

B. Bonanni, S. Gandini, M. Sandri, 2003, Journal of Thrombosis and Haemostasis.

Effect of Transdermal Estradiol and Oral Conjugated Estrogen on C-Reactive Protein in Retinoid-Placebo Trial in Healthy Women

M. Cazzaniga, B. Bonanni, S. Pecorelli, 2002, Circulation.

Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer

B. Bonanni, L. Baglietto, D. Serrano, 2004, Breast Cancer Research and Treatment.

Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis.

S. Gandini, A. Guerrieri-Gonzaga, D. Macis, 2014, International journal of epidemiology.

Benefit of low‐dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS

M. Cazzaniga, B. Bonanni, I. Šestak, 2016, International journal of cancer.

The effect of metformin on apoptosis in a breast cancer presurgical trial

M. Cazzaniga, B. Bonanni, G. Pruneri, 2013, British Journal of Cancer.

Breast conservative surgery for well-differentiated ductal intraepithelial neoplasia: Risk factors for ipsilateral breast tumor recurrence.

A. Luini, B. Bonanni, G. Viale, 2014, Breast.

Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences

R. Gelber, A. Goldhirsch, A. Coates, 2014, Breast Cancer Research and Treatment.

Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.

A. Luini, B. Bonanni, A. Goldhirsch, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Update on tamoxifen to prevent breast cancer. The Italian Tamoxifen Prevention Study.

M. Cazzaniga, B. Bonanni, N. Rotmensz, 2000, European journal of cancer.

Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women

Laura Baglietto, Sara Gandini, Enrico Cassano, 2008, Breast Cancer Research and Treatment.

Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.

M. Cazzaniga, B. Bonanni, P. Magni, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized Biomarker Trial of Anastrozole or Low-Dose Tamoxifen or Their Combination in Subjects with Breast Intraepithelial Neoplasia

A. Luini, M. Cazzaniga, B. Bonanni, 2009, Clinical Cancer Research.

Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype

B. Bonanni, G. Pruneri, G. Viale, 2013, British Journal of Cancer.

Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.

M. Cazzaniga, B. Bonanni, L. Mariani, 2006, Maturitas.

Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo

M. Cazzaniga, B. Bonanni, D. Radice, 2012, BMC Cancer.

Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide

M. Cazzaniga, B. Bonanni, S. Gandini, 2013, Breast Cancer Research and Treatment.

Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study.

M. Cazzaniga, B. Bonanni, A. Goldhirsch, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Estrogen receptor in breast ductal carcinoma in situ: good cop, bad cop?

G. Pruneri, A. Decensi, A. Guerrieri-Gonzaga, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Computer-assisted image analysis of breast fine needle aspiration in a randomized chemoprevention trial of fenretinide vs. placebo in HRT users.

B. Bonanni, L. Mariani, G. Pelosi, 2008, Breast.

A Phase I-II Preoperative Biomarker Trial of Fenretinide in Ascitic Ovarian Cancer

L. Baglietto, R. Montironi, G. Viale, 2006, Cancer Epidemiology Biomarkers & Prevention.

Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial.

B. Bonanni, P. Brown, J. Lee, 2023, JAMA oncology.

Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial

J. Cuzick, M. Cazzaniga, B. Bonanni, 2015, Cancer Prevention Research.

Metformin and breast cancer risk.

S. Gandini, A. Decensi, M. Puntoni, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo

M. Cazzaniga, B. Bonanni, D. Radice, 2012, BMC Cancer.

Alternative dosing of exemestane in postmenopausal women with ER-positive breast cancer. Design and methods of a randomized presurgical trial

B. Bonanni, P. Brown, E. Szabo, 2021, Contemporary clinical trials.

Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Recurrence in Breast Noninvasive Neoplasia: A 10-Year Follow-Up of TAM-01 Study

B. Bonanni, M. Digennaro, L. Cortesi, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer

B. Bonanni, G. Mellgren, S. Gandini, 2019, The Pharmacogenomics Journal.

Vitamin D Supplementation and Adherence to World Cancer Research Fund (WCRF) Diet Recommendations for Colorectal Cancer Prevention: A Nested Prospective Cohort Study of a Phase II Randomized Trial

B. Bonanni, S. Gandini, M. Zampino, 2023, Biomedicines.

A Novel Automated Immunoassay Platform to Evaluate the Association of Adiponectin and Leptin Levels with Breast Cancer Risk

J. Cuzick, B. Bonanni, I. Šestak, 2021, Cancers.

Germline pathogenic variants in metaplastic breast cancer patients and the emerging role of the BRCA1 gene

B. Bonanni, S. Gandini, G. Corso, 2023, European Journal of Human Genetics.

Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience

B. Bonanni, S. Gandini, C. Zanzottera, 2023, Genes.

Abstracts of the 4th meeting of the European Hereditary Tumour Group, Barcelona, Spain, October 17–19th, 2019

B. Bonanni, L. Kowalski, L. Bernard, 2020, Familial Cancer.

Ki-67 Expression after Tamoxifen Given Preoperatively Predicts Disease Free Survival and Overall Survival in Women with Operable ER-Positive Breast Cancer.

A. Luini, M. Cazzaniga, B. Bonanni, 2009 .

Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial

J. Cuzick, M. Cazzaniga, B. Bonanni, 2015, Cancer Prevention Research.

Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials.

M. Cazzaniga, P. Veronesi, D. Serrano, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Is it Time to Test Metformin in Breast Cancer Clinical Trials?

M. Cazzaniga, B. Bonanni, A. Decensi, 2009, Cancer Epidemiology Biomarkers & Prevention.

Alternative dosing regimen of exemestane in a randomized presurgical trial: the role of obesity in biomarker modulation

Parijatham S. Thomas, D. Serrano, L. Vornik, 2024, NPJ breast cancer.

Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ.

E. Guerini-Rocco, C. Fumagalli, M. Lazzeroni, 2024, European journal of cancer.

Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.

M. Cazzaniga, B. Bonanni, P. Magni, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study

D. Serrano, H. Johansson, M. Lazzeroni, 2024, Cancers.

A Mediation Analysis of Obesity and Adiponectin Association with Postmenopausal Breast Cancer Risk: A Nested Cohort Study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial

I. Šestak, A. Decensi, H. Johansson, 2024, Nutrients.